Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00718835 · ClinicalTrials.gov registry record · Phase 2
Incentive-based Smoking Cessation for Methadone Patients
A Phase 2 study, sponsored by University of Vermont Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
NCT00718835 is a Phase 2 study that has completed, run by University of Vermont Medical Center. The registered enrollment target is 170 participants.
The verdict
NCT00718835, a Phase 2 study, has completed, sponsored by University of Vermont Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
Study Summary
The prevalence of cigarette smoking among patients receiving opioid agonist treatment, such as methadone or buprenorphine maintenance, is more than three-fold that of the general population and is associated with increased morbidity and mortality. The overarching goal of this project is to systematically develop a voucher-based contingency-management (CM) intervention for promoting initial and longer-term abstinence from cigarette smoking in patients receiving methadone or buprenorphine treatment for their opioid abuse.
Interventions
- BEHAVIORAL incentive-based contingency management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2007-06 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00718835
The ClinicalTrials.gov registry entry for NCT00718835 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont Medical Center, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which incentive-based contingency management is the first listed.
NCT00718835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00718835 about?
NCT00718835 is a clinical study titled "Incentive-based Smoking Cessation for Methadone Patients". The prevalence of cigarette smoking among patients receiving opioid agonist treatment, such as methadone or buprenorphine maintenance, is more than three-fold that of the general population and is associated with increased morbidity and mortality. The overarching goal of this project is to systemati...
What is the current status of trial NCT00718835?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2007-06. Estimated completion is 2013-06.
What interventions are being tested in trial NCT00718835?
The interventions under investigation include: incentive-based contingency management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00718835?
This trial is sponsored by University of Vermont Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.